Skip to main content
Tech.euFundingExplorerBeta

Araris Biotech

Araris Biotech is a biotechnology platform enables the attachment of any payload to ‘off the shelf’ antibodies.

Araris Biotech has raised €41M across 3 funding rounds from 9 investors, most recently a round in May 2023. Based in Zurich, Switzerland; founded 2019; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€41M
€40,993,957
Funding rounds
3
Investors
9
distinct backers
Active since
2020-10
latest 2023-05

Funding by year

EUR raised per year
Araris Biotech — funding by year — interactive chart.
Data table
Araris Biotech — funding by year
2020€14M
2022€24M
2023€2.5M

Signals

High confidence
Raise-next likelihood5
base rate 30% for Other
  • ▼ Past typical raise window
  • ▼ Down/flat last round
  • ▼ Low backer re-investment
Exit likelihood11
base rate 11% (2+ rounds)
  • ▲ €30M+ raised
  • ▲ 7y since founding (typical exit age)
  • ▼ No recent equity round (debt-only or quiet)

Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds

Similar companies

same sector or country

Global coverage: FundingData